Generated by AI
Maravai LifeSciences Holdings, Inc. Class A Common Stock represents ownership in Maravai LifeSciences Holdings, Inc., a life sciences company focused on products and services that support drug development, vaccine creation, cell and gene therapy research, and diagnostics. The company serves biopharmaceutical, biotechnology, and research customers through specialized offerings in nucleic acid production and biologics safety testing. Its product portfolio includes reagents, enzymes, nucleic acid tools, and analytical services used across molecular biology, genomics, and bioprocessing workflows. Maravai LifeSciences plays a role in the broader healthcare and life sciences market by supplying critical inputs that help enable laboratory research, therapeutic development, and quality testing across the drug development process. The company is headquartered in San Diego, California, and its business is organized around current operating segments that address research and production needs in advanced biologics and diagnostics.
Website10770 Wateridge Circle
San Diego, CA, 92121
United States
The latest articles about MRVI.
Summary of Aug 20's posts. Generated by AI.
Summary of Feb 23's posts. Generated by AI.
Summary of Aug 20's posts. Generated by AI.
Investors talking about MRVI also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.